Table 1.
Epstein–Barr virus (EBV) and high-risk human papillomaviruses (HPVs) onco-proteins interactions can occur via β-catenin, JAK/STAT/SRC, PI3k/Akt/mTOR, and/or RAS/MEK/ERK signaling pathways and probably other paths.
The most common pathways of EBV and high-risk HPVs | |
---|---|
HR-HPV Onco-proteins | E5→EGFR→RAS→RAF→MEK→ERK1/ERK2 |
→AKT→mTOR | |
→JAK→STAT→SRC | |
→β-catenin | |
E6→p53→AKT→mTOR | |
E7→pRb→AKT→mTOR | |
EBV Onco-proteins | LMP1→JAK→STAT→SRC |
→β-catenin | |
→PI3K→AKT→mTOR | |
LMP2A→RAS→RAF→MEK→ERK1/ERK2 | |
→AKT→mTOR | |
EBNA1→STAT→SRC | |
→β-catenin |